Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM

European Journal of Immunology

Volumn 29, Issue 2, 1999, Pages 660-668

  Raddrizzani, Laura ^a   Bono, Elisa ^a   Vogt, Anne B ^b   Kropshofer, Harald ^b   Gallazzi, Fabio ^a   Sturniolo, Tiziana ^a   Hämmerling, Günter J ^b   Sinigaglia, Francesco ^a   Hammer, Juergen ^c  

^a ROCHE MILANO RICERCHE   (Italy)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

HLA DM; HLA DR; Peptide binding; Peptide editing; Phage display

Indexed keywords

COLLAGEN TYPE 2; GLYCINE; HLA ANTIGEN CLASS 2; HLA DR1 ANTIGEN; PROLINE;

ARTICLE; HUMAN; HUMAN CELL; PHAGE DISPLAY; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; BACTERIOPHAGES; CATTLE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; SEQUENCE ANALYSIS;

EID: 0033034158     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199902)29:02<660::AID-IMMU660>3.0.CO;2-I     Document Type: Article

References (36)

1. Germain, R. N., MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994. 76: 287-299.
2. Busch, R. and Mellins, E. D., Developing and shedding inhibitions: how MHC class II molecules reach maturity. Curr. Opin. Immunol. 1996, 8: 51-58.
3. Kropshofer, H., Hämmerling, G. J. and Vogt, A. B., How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 1997. 18: 77-82.
4. Roche, P. A., HLA-DM: An in vivo facilitator of MHC class II peptide loading. Immunity 1995. 3: 259-262.
5. Kropshofer, H., Arndt, S. O., Moldenhauer, G., Hämmerling, G. J. and Vogt, A. B., HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH. Immunity 1997. 6: 293-302.
6. Lightstone, L., Hargreaves, R., Bobek, G., Peterson, M., Aichinger, G., Lombardi, G. and Lechler, R., In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM. Proc. Natl. Acad. Sci. USA 1997. 94: 5772-5777.
7. Tourne, S., Miyazaki, T., Wolf, P., Ploegh, H., Benoist, C. and Mathis, D., Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes. Proc. Natl. Acad. Sci. USA 1997. 94: 9255-9260.
8. Katz, J. F., Stebbins, C., Appella, E. and Sant, A. J., Invariant chain and DM edit self peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 1996. 184: 1747-1753.
9. Kropshofer, H., Vogt, A. B., Moldenhauer, G., Hammer, J., Blum, J. S. and Hämmerling, G. J., Editing of the HLA-DR-peptide repertoire by HLA-DM. EMBO J. 1996. 15: 6144-6154.
10. Weber, D. A., Evavold, B. D. and Jensen, P. E., Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996. 274: 618-620.
11. Van Ham, S. M., Grüneberg, U., Malcherek, G., Bröker, I., Melms, A. and Trowsdale, J., Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs. J. Exp. Med. 1996. 184: 2019-2024.
12. Vogt, A. B., Kropshofer, H., Moldenhauer, G. and Hämmerling, G. J., Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM. Proc. Natl. Acad. Sci. USA 1996. 93: 9724-9729.
13. Sloan, V. S., Cameron, P., Porter, G., Gammon, M., Amaya, M., Mellins, E. and Zaller, D. M., Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 1995. 375: 802-806.
14. Denzin, L. K. and Cresswell, P., HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 1995. 82: 155-165.
15. Sherman, M. A., Weber, D. A. and Jensen, P. E., DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 1995. 3: 197-205.
16. Denzin, L. K., Hammond, C. and Cresswell, P., HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 1996. 184: 2153-2165.
17. Sanderson, F., Thomas, C., Neefjes, J. and Trowsdale, J., Association between HLA-DM and HLA-DR in vivo. Immunity 1996. 4: 87-96.
18. Hammer, J. and Sinigaglia, F., in Lefkovits, I. (Ed.), Immunology Methods Manual: The Comprehensive Sourcebook of Techniques, Academic Press, Ltd., London 1997, p. 625-635.
19. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. and Sinigaglia, F., Promiscuous and allele-specific anchors in HLA-DR binding peptides. Cell 1993. 74: 197-203.
20. Hammer, J., Takacs, B. and Sinigaglia, F., Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J. Exp. Med. 1992. 176: 1007-1013.
21. Hammer, J., Belunis, C., Bolin, D., Papadopoulos, J., Walsky, R., Higelin, J., Danho, W., Sinigaglia, F. and Nagy, Z. A., High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. USA 1994. 91: 4456-4460.
22. Hammer, J., Sturniolo, T. and Sinigaglia, F., HLA class II peptide binding specificity and autoimmunity. Adv. Immunol. 1997. 66: 67-100.
23. Chou, P. Y. and Fasman, G. D., Conformational parameters for amino acids in helical, β-sheet, and random coil regions calculated from proteins. Biochemistry 1974. 13: 211-222.
24. Fugger, L., Rothbard, J. B. and Sonderstrup-McDevitt, G., Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur. J. Immunol. 1996. 26: 928-933.
25. Rosloniec, E. F., Brand, D. D., Myers, L. K., Whittington, K. B., Gumanovskaya, M., Zaller, D. M., Woods, A., Altmann, D. M., Stuart, J. M. and Kang, A. H., An HLA-DR1 transgene confers susceptibility to collageninduced arthritis elicited with human type II collagen. J. Exp. Med. 1997. 185: 1113-1122.
26. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an Influenza virus peptide. Nature 1994. 368: 215-221.
27. Lindner, R. and Unanue, E. R., Distinct antigen MHC class II complexes generated by separate processing pathways. EMBO J. 1996. 15: 6910-6920.
28. Ma, C. and Blum, J. S., Receptor-mediated endocytosis of antigens overcomes the requirement for HLA-DM in class II-restricted antigen presentation. J. Immunol. 1997. 158: 1-4.
29. Vergelli, M., Pinet, V., Vogt, A. B., Kalbus, M., Malnati, M., Riccio, P., Long, E. O. and Martin, R., HLA-DR-restricted presentation of purified myelin basic protein is independent of intracellular processing. Eur. J. Immunol. 1997. 27: 941-951.
30. Kropshofer, H., Vogt, A. B., Thery, C., Armandola, E. A., Li, B.-C., Moldenhauer, G., Amigorena, S. and Hämmerling, G. J., A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 1998. 17: 2971-2981.
31. Van Ham, S. M., Tjin, E. P. M., Lillemeier, B. F., Grüneberg, U., Van Meijgaarden, K. E., Pastoors, L., Verwoerd, D., Tulp, A., Canas, B., Rahman, D., Ottenhoff, T. H. M., Pappin, D. J. C., Trowsdale, J. and Neefjes, J., HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 1997. 7: 950-957.
32. Sinigaglia, F., Romagnoli, P., Guttinger, M., Takacs, B. and Pink, J. R. L., Selection of T cell epitopes and vaccine engineering. Methods Enzymol. 1992. 203: 370-386.
33. Cammarota, G., Scheirle, A., Takacs, B., Doran, D. M., Knorr, R., Bannwarth, W., Guardiola, J. and Sinigaglia, F., Identification of a CD4 binding site on the β2 domain of HLA-DR molecules. Nature 1992. 356: 799-801.
34. Denzin, L. K., Robbins, N. F., Carboy-Newcomb, C. and Cresswell, P., Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1994. 1: 595-606.
35. Raddrizzani, L., Sturniolo, T., Guenot, J., Bono, E., Gallazzi, F., Nagy, Z. A., Sinigaglia, F. and Hammer, J., Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. J. Immunol. 1997. 159: 703-711.
36. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C., The three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993. 364: 33-39.